Javelin has launched Dyloject (diclofenac), an injectable formulation of the NSAID.

Dyloject is indicated for acute forms of pain, including renal colic, exacerbations of osteo- and rheumatoid arthritis, acute back pain, acute gout, acute trauma, fractures and post-operative pain

View Dyloject drug record

Further information: Javelin

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more